These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 938543)

  • 1. Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors.
    Sjöholm I; Kober A; Odar-Cederlöf I; Borgåa O
    Biochem Pharmacol; 1976 May; 25(10):1205-13. PubMed ID: 938543
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of uremic toxins and nonesterified fatty acids on drug and thyroid hormone binding in serum.
    Lim CF; Stockigt JR
    Clin Chem; 1998 Nov; 44(11):2380-1. PubMed ID: 9799777
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein binding of diazepam and digitoxin in uremic and normal serum.
    Kober A; Sjöholm I; Borgå O; Odar-Cederlöf I
    Biochem Pharmacol; 1979 Apr; 28(7):1037-42. PubMed ID: 444260
    [No Abstract]   [Full Text] [Related]  

  • 4. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid: binding levels of urate ions in normal and uraemic plasma, and in human serum albumin.
    Farrell PC; Ward RA; Hone PW
    Biochem Pharmacol; 1975 Oct; 24(20):1885-7. PubMed ID: 1191338
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of protein binding inhibitor on cultivated lymphocytes in uremic patients].
    Sanaka T; Kawashima Y; Takahashi F; Takuma T; Ota K; Sugino N
    Nihon Jinzo Gakkai Shi; 1983 Aug; 25(8):1063-9. PubMed ID: 6668745
    [No Abstract]   [Full Text] [Related]  

  • 7. The alteration of plasma proteins in uremia as reflected in the ability to bind diphenylhydantoin.
    Shoeman DW; Benjamin DM; Azarnoff DL
    Ann N Y Acad Sci; 1973 Nov; 226():127-30. PubMed ID: 4520391
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacology: plasma protein binding of drugs.
    Lindup WE; Orme MC
    Br Med J (Clin Res Ed); 1981 Jan; 282(6259):212-4. PubMed ID: 6779954
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of disease on binding of drugs to plasma proteins.
    Reidenberg MM; Affrime M
    Ann N Y Acad Sci; 1973 Nov; 226():115-26. PubMed ID: 4520390
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced in vitro binding of tryptophan by plasma in uremia.
    de Torrente A; Glazer GB; Gulyassy P
    Kidney Int; 1974 Oct; 6(4):222-9. PubMed ID: 4427418
    [No Abstract]   [Full Text] [Related]  

  • 11. Correction of drug binding defects in uremia in vitro by anion exchange resin treatment.
    Lichtenwalner DM; Suh B; Lorber B; Rudnick MR; Craig WA
    Biochem Pharmacol; 1982 Nov; 31(21):3483-7. PubMed ID: 7150368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia.
    Mabuchi H; Nakahashi H
    Clin Chim Acta; 1987 Jul; 167(1):89-96. PubMed ID: 3665090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disease states on plasma protein binding of drugs.
    Reidenberg MM
    Med Clin North Am; 1974 Sep; 58(5):1103-9. PubMed ID: 4607741
    [No Abstract]   [Full Text] [Related]  

  • 14. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA; Evenson MA; Sarver KP; Wagnild JP
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug binding defect of uraemic plasma: unlikely involvement of carbamoylated albumin.
    Clegg LS; Lindup WE
    Biochem Pharmacol; 1982 Sep; 31(17):2791-4. PubMed ID: 7138574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of plasma albumin in relation to decreased drug binding in uremia.
    Boobis SW
    Clin Pharmacol Ther; 1977 Aug; 22(2):147-53. PubMed ID: 407044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of smoking on serum protein composition and the protein binding of drugs.
    Benedek IH; Blouin RA; McNamara PJ
    J Pharm Pharmacol; 1984 Mar; 36(3):214-6. PubMed ID: 6144765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-protein interaction.
    Krasner J
    Pediatr Clin North Am; 1972 Feb; 19(1):51-63. PubMed ID: 5049219
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma protein binding in uremia: extraction and characterization of an inhibitor.
    Depner TA; Gulyassy PF
    Kidney Int; 1980 Jul; 18(1):86-94. PubMed ID: 7218662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A major inhibitor of phenytoin binding to serum protein in uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.